PGK1 and stroke disorder: Terazosin activates HSP90 via phosphoglycerate kinase-1 (PGK1), thereby enhancing tolerance to cellular stress, inhibiting apoptosis, and protecting stressed cells while alleviating stroke symptoms in rats (Chen et al., 2015).